Poly (Hexamethylene Biguanide) Hydrochloride (PHMB) Cas:32289-58-0

We are Poly (Hexamethylene Biguanide) Hydrochloride (PHMB) CAS:32289-58-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests





Synonym: Polyhexamethylene Biguanide Hydrochloride
CAS Number: 32289-58-0
EINECS: 1308068-626-2
 
Chemical & Physical Properties
Molecular Formula: (C₈H₁₇N₅)n.xClH
Molecular Weight: 213.32312
 
Specification
Appearance: Colorless or light-yellow solid
Active ingredient: ≥99%
Water soluble: 100% soluble
Odor: Light ammonia smell
Moisture content: ≤0.5%
Water insoluble matter: ≤0.1%
PH in 1% aqueous solution: >4
Ash: 0.05%
 
Application
PHMB is an environmental-friendly Cationic Polymer. This chemical is water soluble and the aqueous solution is colorless and odorless, broad-spectrum, high-efficiency,low toxicity, good stability, non-flammable and non-explosive. Normally non-corrosive to stainless steel, stainless copper, carbon steel, wood, plastic, etc. PHMB is a high molecular polymer, which is not easily absorbed by tissues, has no corrosive effect, has good stability and is easy to rinse, good biocompatibility. Vitro studies have shown that it is non-toxic to human cells, and the in vivo irritation test results of rabbit and human hand skin show that it has no irritation to animal and human skin. It is widely used in textile printing and dyeing, animal husbandry, aquaculture, medical sterilization and daily disinfection.
 
Package and Storage
20kgs/drum. Store in a cool, dry, well-ventilated warehouse. Keep away from fire and heat
sources. Prevent direct sunlight. The package is sealed and kept away from moisture. Store separately from oxidizers and flammable materials. Do not store them together. The storage area should be equipped with suitable materials to contain the leakage.



Market News:Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity. 2-BROMO-1-(5-METHYL-3-PHENYLISOXAZOL-4-YL)ETHAN-1-ONE manufacturer.For Franco Stevanato, tapping public markets will give the company the freedom to keep innovating as it enters the next chapter of its 70-plus-year history. 4-Methyl-3-nitrobenzoyl chloride supplier.Events, Hatzalah of South Florida, and Ygrene and in partnership with the Shul of Bal Harbour we are able to continue this mission by providing first and last month rent as well as the security deposit for these families If this fund grows bigger, we will be able to continue to contribute funds directly for the rents.” Michael Capponi
“During this challenging time for the survivors, the uncertainty of not knowing where they will live exacerbates an already extremely painful and tragic situation. We are committed to the relocation efforts of all of the survivors through our partnership with Global Empowerment Mission.” Rabbi Zalman Lipskar, The Shul of Bal Harbour.
“We are devastated by the loss suffered by the victims, families of victims and the community at the hands of the Surfside tragedy. It is an honor to contribute to GEM’s Champlain Survivor Relocation Fund to provide safe and comfortable homes for survivors to help them get back on their feet, ” said Ygrene CEO, Jim Reinhart.
Baclofen is a muscle relaxant drug indicated for the treatment of muscle pain, spasms, and stiffness in people with multiple sclerosis, spinal cord injury, or disease.
This is Beximco Pharma’s ninth Abbreviated New Drug Application fully developed in-house and successfully approved for the US market since the Company’s oral solid dosage facility was approved by the US FDA in June 2015.
According to IQVIA audited market data, there are currently nine active players for Baclofen in the US market, which generated sales of more than $110 million in 2020.
Mr. Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said: We are pleased to have received FDA approval of Baclofen, a commonly prescribed medicine in the US, as we continue to leverage our core strengths in R&D and manufacturing to develop and deliver important generic products to patients. 2-Chloro-5-iodobenzonitrile producer.